Akums Drugs And Pharmaceuticals Q2 Results
- BSE: 544222
- NSE: AKUMS
- ISIN: INE09XN01023
- Sector: -
BSE
672.4
32.00 (5.00%)
32.00 (5.00%)Volume8.29 K
Updated: Mon 25 Nov, 2024 | 15:59:34
NSE
672.132.00 (5.00%)
32.00 (5.00%)Volume28.17 K
Updated: Mon 25 Nov, 2024 | 15:28:54
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹1,033.09 Cr.(1.37%)
- Operating Profit₹90.02 Cr.(-0.07%)
- Profit After Tax₹65.21 Cr.(8.37%)
- Operating Margin8.71%(171.36%)
Note: Comparison is on YoY basis
Quarterly - Akums Drugs And Pharmaceuticals Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 24 | QoQ Comp | Sep 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 1,033.09 | 1,019.11 | -% | 2,151.14 | -% |
| Selling/ General/ Admin Expenses Total | 180.10 | 176.22 | -% | 445.60 | -% |
| Depreciation/ Amortization | 34.86 | 34.06 | -% | 60.14 | -% |
| Other Operating Expenses Total | 135.85 | 122.74 | -% | 29.09 | -% |
| Total Operating Expense | 943.07 | 929.03 | -% | 1,958.27 | -% |
| Operating Income | 90.02 | 90.09 | -% | 192.87 | -% |
| Net Income Before Taxes | 91.59 | 87.48 | -% | -71.67 | -% |
| Net Income | 65.21 | 60.17 | -% | -156.42 | -% |
| Diluted Normalized EPS | 4.19 | 4.21 | -% | -8.82 | -% |
EQUITY QUICK LINKS
FROM MARKETS
RELATED LINKS
Trending Stocks
- Markets
01NTPC Green Energy IPO allotment date likely today. GMP, how to check status online
2 min read07:58 AM IST - Markets
02Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — Nov 25
4 min read06:15 AM IST - Markets
03Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST